COO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $56.91
Market Cap (MRQ) $10.82B
P/E (TTM) 19.5
EPS (TTM) $2.92
Revenue (TTM) $4.24B
Div Yield 0.00%
ROE (TTM) 6.8%
Debt/Equity (MRQ) 0.3
52W Range $51–$90

COO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 3
Ex-date Split Type
Feb. 20, 2024 4-for-1 Forward
Nov. 25, 2002 2-for-1 Forward
Sept. 22, 1995 1-for-3 Reverse

About The Cooper Companies, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.

History

Parker Montgomery, a lawyer, bought Martin H. Smith Co. in 1958. The company was renamed to Cooper, Tinsley Laboratories, Inc. in 1961. Its name was changed to Cooper Laboratories Inc. in 1967, and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.

In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.

The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).

Currently, the firm operates as two business units: CooperVision and CooperSurgical. CooperVision serves contact lens wearers and eye care practitioners. Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia.

CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility. It is headquartered in Trumbull, Connecticut.

Acquisitions

Ocular Sciences Inc. was acquired by CooperVision in 2005.

CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021. A month later, in March, the company acquired Safe Obstetric Systems, and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.

In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million. During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees15,000 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$4.09B
2016-10-31 → 2025-10-31
EPS$1.87
2016-10-31 → 2025-10-31
Free Cash Flow$434M
2016-10-31 → 2025-10-31
Net margin13.5%
2016-10-31 → 2025-10-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend COO 5Y avg Peer Median Verdict
P/E (TTM) 19.55Y avg ≈36.1 ≈36.1 28.5 Undervalued
P/S (TTM) 2.65Y avg ≈2.5 ≈2.5 2.1 Overvalued
P/B (MRQ) 1.35Y avg ≈1.2 ≈1.2 2.1 Undervalued
EV / EBITDA 12.85Y avg ≈13.5 ≈13.5 16.6 Fair value
Price / FCF (TTM) 16.05Y avg ≈27.9 ≈27.9 · ·
Price / Cash Flow (TTM) 10.55Y avg ≈13.0 ≈13.0 17.6 Fair value
EV / Revenue 3.35Y avg ≈3.1 ≈3.1 · ·
EV / FCF 31.25Y avg ≈34.4 ≈34.4 · ·
Price / Tangible Book (MRQ) 1.65Y avg ≈3.8 ≈3.8 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Dividend Yield0.00%
Payout Ratio0.00%
Annualized Payout≈$0.01Paid semi-annually
Ex-dateAmountCurrencyYield
Jul 26, 2023$0.01USD≈0.02%
Jan 20, 2023$0.01USD≈0.02%
Jul 26, 2022$0.01USD≈0.02%
Jan 20, 2022$0.01USD≈0.02%
Jul 26, 2021$0.01USD≈0.01%
Jan 21, 2021$0.01USD≈0.02%
Jul 22, 2020$0.01USD≈0.02%
Jan 22, 2020$0.01USD≈0.02%
Jul 22, 2019$0.01USD≈0.02%
Jan 18, 2019$0.01USD≈0.02%
Jul 20, 2018$0.01USD≈0.02%
Jan 22, 2018$0.01USD≈0.02%
Jul 19, 2017$0.01USD≈0.02%
Jan 19, 2017$0.01USD≈0.03%
Jul 20, 2016$0.01USD≈0.03%
Jan 20, 2016$0.01USD≈0.05%
Jul 22, 2015$0.01USD≈0.03%
Jan 21, 2015$0.01USD≈0.04%
Jul 22, 2014$0.01USD≈0.04%
Jan 22, 2014$0.01USD≈0.05%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 3.9%
PeriodReportEPS ActualEPS EstSurprise
Sept. 30, 2026 Sep 9, 2026 $1.15 $1.13 1.8%
June 30, 2026 Jun 4, 2026 $1.21 $1.11 9.3%
March 31, 2026 $1.10 $1.04 5.7%
Dec. 31, 2025 $1.15 $1.12 2.3%
Sept. 30, 2025 $1.10 $1.08 1.9%
June 30, 2025 $0.96 $0.94 2.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $4.09B$3.90B$3.59B$3.31B$2.92B$2.43B$2.65B$2.53B$2.14B$1.97B$1.80B$1.72B
Cost of Revenue $1.41B$1.30B$1.24B$1.17B$967M$896M$897M$900M$773M$794M$727M$626M
Gross Profit $2.68B$2.60B$2.36B$2.14B$1.96B$1.53B$1.76B$1.63B$1.37B$1.17B$1.07B$1.09B
R&D Expense $172M$155M$137M$110M$93M$93M$87M$85M$69M$65M$70M$66M
SG&A Expense $1.63B$1.53B$1.50B$1.34B$1.21B$992M$996M$973M$799M$723M$712M$683M
Operating Income $683M$706M$533M$508M$506M$312M$547M$403M$429M$324M$237M$306M
Interest Expense ··$105M$57M$23M$37M$68M$83M$33M$26M$18M$8M
Other Non-op $-16M$-9M$-15M$25M$9M$-8M$-1M$12M$-2M$-2M$-3M$-2M
Pretax Income $566M$582M$413M$475M$492M$266M$477M$332M$394M$296M$216M$296M
Income Tax $192M$190M$119M$90M$-2.45B$28M$11M$192M$21M$21M$10M$25M
Net Income $375M$392M$294M$386M$2.94B$238M$467M$140M$373M$274M$204M$270M
EPS (Basic) $1.88$1.97$1.49$1.95$59.80$4.85$9.44$2.85$7.63$5.65$4.20$5.61
EPS (Diluted) $1.87$1.96$1.48$1.94$59.16$4.81$9.33$2.81$7.52$5.59$4.14$5.51
Shares (Basic) 199,100,000198,900,000197,900,000197,400,00049,200,00049,100,00049,400,00049,100,00048,900,00048,500,00048,500,00048,061,000
Shares (Diluted) 200,000,000200,400,000199,300,000198,800,00049,800,00049,600,00050,000,00049,700,00049,600,00049,000,00049,200,00049,000,000
EBITDA $1.06B$1.08B$901M$508M$506M$312M$828M$678M$618M$522M$428M$445M
Balance Sheet 29
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $111M$108M$121M$138M$96M$116M$89M$78M$89M$101M$16M$25M
Receivables $829M$717M$610M$558M$515M$435M$435M$375M$317M$291M$283M$276M
Inventory $846M$803M$736M$629M$586M$570M$507M$469M$454M$418M$420M$382M
Prepaid Expense $321M$324M$239M$209M$179M$152M$132M$170M$94M$78M$81M$68M
Current Assets $2.11B$1.95B$1.70B$1.53B$1.47B$1.27B$1.16B$1.09B$953M$937M$841M$792M
PP&E (Net) $2.08B$1.86B$1.63B$1.41B$1.35B$1.28B$1.13B$976M$910M$878M$967M$937M
PP&E (Gross) $3.91B$3.56B$3.18B$2.80B$2.66B$2.47B$2.19B$1.93B$1.76B$1.60B$1.65B$1.53B
Accum. Depreciation $1.83B$1.70B$1.55B$1.39B$1.31B$1.19B$1.06B$954M$847M$726M$684M$589M
Goodwill $3.85B$3.84B$3.62B$3.61B$2.57B$2.45B$2.43B$2.39B$2.35B$2.16B$2.20B$2.22B
Intangibles $1.59B$1.79B$1.71B$1.89B$1.27B$1.29B$1.41B$1.52B$505M$441M$411M$454M
Other Non-current Assets $689M$661M$637M$588M$401M$105M$67M$74M$76M$52M$39M$39M
Total Assets $12.39B$12.32B$11.66B$11.49B$9.61B$6.74B$6.27B$6.11B$4.86B$4.48B$4.46B$4.46B
Accounts Payable $300M$260M$262M$249M$161M$176M$150M$146M$142M$107M$117M$116M
Short-term Debt $47M$32M$44M$396M$83M$409M$564M$37M$23M$226M$244M$102M
Current Liabilities $1.11B$1.02B$969M$1.28B$732M$1.00B$1.11B$536M$396M$543M$569M$442M
Capital Leases $240M$231M$216M$206M$232M$237M······
Deferred Tax $93M$96M$102M$150M$24M$26M$28M$31M$39M$38M$31M$70M
Other Non-current Liabilities $283M$312M$239M$225M········
Total Liabilities $4.16B$4.23B$4.11B$4.32B$2.66B$2.91B$2.65B$2.81B$1.68B$1.78B$1.79B$1.87B
Long-term Debt ·······$1.99B$1.15B$1.32B$1.11B$1.28B
Total Debt $2.50B$2.58B$2.56B$2.35B$1.40B$1.38B$1.26B$2.02B$1.17B$1.54B$1.35B$1.38B
Common Stock $22M$22M$22M$5M$5M$5M$5M$5M$5M$5M$5M$5M
Paid-in Capital $1.98B$1.92B$1.82B$1.77B$1.72B$1.65B$1.61B$1.57B$1.53B$1.49B$1.43B$1.39B
Retained Earnings $7.64B$7.27B$6.88B$6.58B$6.20B$3.26B$3.03B$2.58B$2.43B$2.05B$1.78B$1.58B
Treasury Stock $995M$706M$710M$714M$640M$617M$571M$415M$415M$360M$360M$295M
AOCI $-406M$-422M$-454M$-467M$-341M$-472M$-447M$-431M$-375M$-490M$-192M$-106M
Stockholders' Equity $8.24B$8.08B$7.55B$7.17B$6.94B$3.82B$3.63B$3.31B$3.18B$2.70B$2.67B$2.57B
Liabilities + Equity $12.39B$12.32B$11.66B$11.49B$9.61B$6.74B$6.27B$6.11B$4.86B$4.48B$4.46B$4.46B
Shares Outstanding 195,900,000199,600,000198,100,00049,300,00049,300,00049,100,000··48,800,00048,800,00048,300,00048,100,000
Cash Flow 18
Metric Trend 202520242023202220212020201920182017201620152014
D&A $377M$375M$368M$346M$309M·$281M$275M$188M$198M$191M$138M
Stock-based Comp $70M$75M$62M$54M$44M$38M$35M$43M$37M$30M$33M$37M
Deferred Tax $135M$119M$45M$54M$-2.50B$-900.0K$-16M$3M$-7M$-11M$6M$-16M
Amort. of Intangibles $199M$201M$186M$180M$146M$137M$146M$147M$68M$61M$52M$36M
Other Non-cash $-162M$-252M$-161M···$-54M$208M$2M$18M$-42M$26M
Operating Cash Flow $796M$709M$608M$692M$739M$487M$713M$669M$594M$510M$391M$455M
CapEx $362M$421M$392M$242M$214M$310M$292M$194M$127M$153M$243M$238M
Investing Cash Flow $-373M$-765M$-449M$-1.83B$-450M$-364M$-351M$-1.52B$-381M$-419M$-288M$-1.35B
Debt Issued $3.11B$3.52B$2.12B$1.51B$1.43B$3.20B$1.14B$2.75B$1.41B$1.58B$1.20B$2.56B
Net Debt Issued $-94M$17M$170M$950M$12M$-30M$-725M$836M$49M$117M$-171M$895M
Stock Repurchased $290M$0$0$78M$25M$48M$156M$0$55M$0$67M$76M
Net Stock Activity $-290M$0$0$-78M$-25M$-48M$-156M$0$-55M$0$-67M$-76M
Dividends Paid $0$0$3M$3M$3M$3M$3M$3M$3M$3M$3M$3M
Financing Cash Flow $-426M$39M$-174M$1.19B$-311M$-96M$-351M$844M$-228M$-1M$-107M$842M
Net Change in Cash $3M$-13M$-18M$42M$-20M$27M$9M$-9M$-12M$84M$-9M$-52M
Taxes Paid ·······$19M$16M$29M$12M$16M
Free Cash Flow $434M$288M$215M$450M$524M$176M$421M$475M$466M$357M$148M$217M
Levered FCF ··$140M$404M$386M··$440M$435M$333M$131M$209M
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 65.5%66.6%65.6%64.7%66.9%63.1%66.2%64.5%63.8%59.6%59.6%63.5%
Operating Margin 16.7%18.1%14.8%15.3%17.3%12.8%20.6%15.9%20.1%16.5%13.2%17.8%
Net Margin 9.2%10.1%8.2%11.7%100.8%9.8%17.6%5.5%17.4%13.9%11.3%15.7%
Pretax Margin 13.8%14.9%11.5%14.4%16.8%··13.1%18.4%15.0%12.0%17.3%
EBITDA Margin 25.9%27.8%25.1%15.3%17.3%12.8%31.2%26.8%28.9%26.6%23.8%25.9%
ROA 3.0%3.3%2.5%3.7%36.0%3.7%7.5%2.5%8.0%6.1%4.6%7.1%
ROE 4.6%5.0%4.0%5.5%54.7%6.4%13.0%4.3%12.7%10.2%7.8%10.8%
ROIC 4.2%4.5%3.8%4.3%36.3%··3.2%9.3%7.1%5.6%7.1%
Liquidity & Solvency 5
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 1.91.91.81.22.01.31.02.02.41.71.51.8
Quick Ratio 0.80.80.80.50.80.50.50.81.00.70.50.7
Debt / Equity 0.30.30.30.30.20.40.30.60.40.60.50.5
LT Debt / Equity 0.30.30.30.30.20.40.30.60.40.40.40.5
Interest Coverage ··5.18.921.98.58.04.912.812.413.138.5
Efficiency 3
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.30.30.30.30.40.40.40.50.50.40.40.5
Inventory Turnover 1.71.71.81.91.71.71.82.01.81.91.81.7
Receivables Turnover 5.35.96.26.26.15.66.67.37.06.86.46.8
Per Share 7
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $42.06$40.50$152.54$145.53$140.81···$65.08$55.34$55.26$53.38
Revenue / Share $20.46$19.44$72.15$66.57$58.68$49.01$53.07$50.96$43.12$40.14$36.54$35.09
Cash Flow / Share $3.98$3.54$12.20$13.93$14.83$9.81$14.26$13.46$11.97$10.40$7.95$9.29
Cash / Share $0.56$0.54$2.44$2.80$1.95···$1.82$2.07$0.34$0.52
Dividend / Share ··$0.01$0.01········
Dividend Paid / Share ··$0.03$0.03$0.03$0.03$0.03$0.03$0.03$0.03$0.03$0.03
EPS (TTM) $1.87$1.96$1.48$1.94$59.16$4.81$9.33$2.81$7.52$5.59$4.14$5.51
Growth Rates 9
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5.1%8.4%8.6%13.2%20.2%·······
Revenue CAGR 3Y 7.3%10.1%13.9%·········
Revenue CAGR 5Y 11.0%···········
EPS YoY -4.6%32.4%-23.7%-96.7%1129.9%·······
EPS CAGR 3Y -1.2%-67.9%-32.5%·········
EPS CAGR 5Y -17.2%···········
Net Income YoY -4.4%33.3%-23.7%-86.9%1135.2%·······
Net Income CAGR 3Y -0.95%-48.9%7.3%·········
Net Income CAGR 5Y 9.5%···········
Valuation (TTM) 17
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $4.09B$3.90B$3.59B$3.31B$2.92B$2.43B$2.65B$2.53B$2.14B$1.97B$1.80B$1.72B
Net Income TTM $375M$392M$294M$386M$2.94B$238M$467M$140M$373M$274M$204M$270M
Market Cap $13.70B$20.89B$3.86B$3.37B$5.14B···$2.93B$2.15B$1.84B$1.97B
Enterprise Value $16.09B$23.37B$6.30B$5.58B$6.44B···$4.02B$3.59B$3.18B$3.33B
P/E 37.453.452.735.21.816.67.823.08.07.99.27.4
P/S 3.35.41.11.01.8···1.41.11.01.1
P/B 1.72.60.50.50.7···0.90.80.70.8
P / Tangible Book 4.98.51.72.01.7·······
P / Cash Flow 17.229.56.44.97.0···4.94.24.74.3
P / FCF 31.672.517.97.59.8···6.36.012.49.1
EV / EBITDA 15.221.67.011.012.7···6.56.97.47.5
EV / FCF 37.181.129.312.412.3···8.610.121.515.4
EV / Revenue 3.96.01.81.72.2···1.91.81.81.9
Dividend Yield 0.00%0.00%0.08%0.09%0.06%···0.10%0.14%0.16%0.15%
Earnings Yield 2.7%1.9%1.9%2.8%56.8%6.0%12.8%4.3%12.5%12.7%10.9%13.5%
Payout Ratio 0.00%0.00%1.0%0.78%0.10%1.3%0.64%2.1%0.78%1.1%1.4%1.1%
Annual Payout $0$0$3M$3M$3M$3M$3M$3M$3M$3M$3M$3M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-10-312024-10-312023-10-312022-10-312021-10-31
Revenue $4.09B $3.90B $3.59B $3.31B $2.92B
Gross Margin % 65.5% 66.6% 65.6% 64.7% 66.9%
Operating Margin % 16.7% 18.1% 14.8% 15.3% 17.3%
Net Income $375M $392M $294M $386M $2.94B
Diluted EPS $1.87 $1.96 $1.48 $1.94 $59.16

Institutional owners (13F) 734 filers · $15.9B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 734
Value held $15.9B
New positions 110
Exited positions 98
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
110 (-5 vs prior Q) 98 (+14 vs prior Q) 259 (+25 vs prior Q) 236 (-6 vs prior Q) +2.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $1,930,069,728 23,548,923 12.11% Shares
BlackRock, Inc. $1,077,762,042 15,029,453 6.76% Shares
VANGUARD CAPITAL MANAGEMENT LLC $914,931,325 12,758,769 5.74% Shares
STATE STREET CORP $637,691,430 8,892,643 4.00% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $621,703,470 8,669,690 3.90% Shares
BROWNING WEST LP $515,984,142 7,195,428 3.24% Shares
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $389,405,563 5,430,282 2.44% Shares
GEODE CAPITAL MANAGEMENT, LLC $382,865,202 5,359,812 2.40% Shares
FRANKLIN RESOURCES INC $365,497,867 5,096,888 2.29% Shares
GENERATION INVESTMENT MANAGEMENT LLP $356,303,541 4,968,673 2.24% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $287,152,440 4,004,357 1.80% Shares
AQR CAPITAL MANAGEMENT LLC $285,686,067 4,022,614 1.79% Shares
Longview Partners (Guernsey) LTD $282,537,902 3,940,007 1.77% Shares
UBS Group AG $281,964,653 3,932,013 1.77% Shares
CITADEL ADVISORS LLC $277,689,589 3,872,397 1.74% Shares
Invesco Ltd. $264,254,073 3,685,038 1.66% Shares
JANA Partners Management, LP $256,899,641 3,582,480 1.61% Shares
WELLINGTON MANAGEMENT GROUP LLP $248,758,476 3,468,951 1.56% Shares
DIMENSIONAL FUND ADVISORS LP $239,621,575 3,341,607 1.50% Shares
JANUS HENDERSON GROUP PLC $219,298,853 3,067,125 1.38% Shares
LONDON CO OF VIRGINIA $207,821,082 2,898,075 1.30% Shares
Diamond Hill Capital Management, LLC (Investment Advisor) $195,854,209 2,731,198 1.23% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $187,836,665 2,343,776 1.18% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $180,899,937 2,530,069 1.14% Shares
BARCLAYS PLC $152,030,580 2,120,075 0.95% Shares
BANK OF AMERICA CORP /DE/ $144,125,264 2,009,835 0.90% Shares
River Road Asset Management, LLC $142,048,546 1,980,875 0.89% Shares
Sustainable Growth Advisers, LP $139,698,824 1,948,108 0.88% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $132,231,017 1,843,969 0.83% Shares
MORGAN STANLEY $129,451,390 1,805,205 0.81% Shares
NORTHERN TRUST CORP $122,198,356 1,704,063 0.77% Shares
Gates Capital Management, Inc. $121,088,717 1,688,589 0.76% Shares
Alecta Tjanstepension Omsesidigt $112,082,730 1,563,000 0.70% Shares
MANNING & NAPIER ADVISORS LLC $107,938,609 1,505,210 0.68% Shares
GOLDMAN SACHS GROUP INC $107,170,245 1,494,495 0.67% Shares
Amundi $101,548,173 1,416,095 0.64% Shares
Focus Partners Wealth $101,143,265 1,410,461 0.63% Shares
Findlay Park Partners LLP $92,075,640 1,284,000 0.58% Shares
WELLS FARGO & COMPANY/MN $82,870,197 1,155,630 0.52% Shares
VANGUARD FIDUCIARY TRUST CO $78,580,965 1,095,816 0.49% Shares
Holocene Advisors, LP $77,495,348 1,080,677 0.49% Shares
Bank of New York Mellon Corp $73,642,162 1,026,945 0.46% Shares
Balyasny Asset Management L.P. $71,022,946 990,419 0.45% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $69,128,942 964,007 0.43% Shares
FMR LLC $66,919,501 933,197 0.42% Shares
ENVESTNET ASSET MANAGEMENT INC $63,808,602 889,815 0.40% Shares
JPMORGAN CHASE & CO $63,430,969 879,426 0.40% Shares
DEUTSCHE BANK AG\ $61,203,267 853,483 0.38% Shares
Legal & General Group Plc $60,521,302 843,973 0.38% Shares
TORONTO DOMINION BANK $56,349,846 785,802 0.35% Shares

Show all 734 institutional owners →

Company insiders 51 insiders · 25 officers · 21 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Robert D Auerbach Special Advisor to the CEO Feb. 1, 2021 M 2,759 0 0 $0
REMMELL PAUL L Pres & CEO - CooperSurgical July 14, 2017 M 1,352 0 0 $0
Nicholas J Pichotta Pres, CEO Cooper Medical, Inc. Jan. 8, 2014 M 10,697 0 0 $0
Brian G Andrews EVP, CFO & Treasurer Dec. 10, 2024 A 8,537 0 0 $0
Gregory W Matz SVP, CFO & CRO June 13, 2016 M 15,123 0 0 $0
Steven M Neil EVP & CFO Jan. 16, 2008 P 4,300 0 0 $0
John J Calcagno CFO - CooperVision Oct. 25, 2007 A 0 0 0 $0
Gerard H Warner III President, CooperVision, Inc. Jan. 8, 2026 M 23,852 0 0 $0
Holly R Sheffield President, CSI Jan. 8, 2026 M 43,261 1 0 $99,322
John Arthur Weber President, CooperVision, Inc. Jan. 8, 2014 M 15,260 0 0 $0
Dennis Murphy President Americas, CVI Sept. 11, 2009 M 0 0 0 $0
Gregory A Fryling Pres & COO - CVI Oct. 24, 2006 A 3,790 0 0 $0
Agostino Ricupati SVP & CAO April 1, 2025 M 8,020 0 0 $0
Nicholas Khadder VP, General Counsel & Corp Sec Jan. 8, 2025 M 2,506 0 0 $0
Mark J Drury VP, General Counsel & Sec. Jan. 8, 2022 M 2,197 0 0 $0
Randal Golden VP, General Counsel & Sec. Feb. 3, 2020 M 1,673 0 0 $0
Carol R Kaufman EVP, Sec. & Chief Gov. Officer April 11, 2018 G 45,898 0 0 $0
Tina Maloney VP, Corporate Controller Jan. 8, 2017 M 2,874 0 0 $0
Rodney Folden VP & Corporate Controller Jan. 8, 2014 M 8,592 0 0 $0
Eugene J Midlock VP Tax Jan. 9, 2012 M 2,137 0 0 $0
Jeffrey Alan Mclean Exec VP, Comm. Strategies-CVI Dec. 11, 2008 A 0 0 0 $0
Christopher J Marmo VP, R&D of CooperVision, Inc. Oct. 24, 2006 A · 0 0 $0
Norris B Battin VP, Investor Relations Oct. 24, 2006 A 4,000 0 0 $0
David Acosta Treasurer April 8, 2005 S 10,000 0 0 $0
Stephen Whiteford VP, Corporate Controller Jan. 20, 2004 M 15,052 0 0 $0
Lawrence E. Kurzius Director Sept. 16, 2026 P 31,099 3 0 $1,253,500
Walter M Rosebrough Jr Director Sept. 14, 2026 P 20,000 2 0 $541,640
Keel Paul A Director Sept. 11, 2026 P 4,701 1 0 $249,999
Barbara Carbone Director April 1, 2026 A 3,050 0 0 $0
Maria Rivas Director April 1, 2026 A 3,322 1 0 $82,130
Colleen Jay Director April 1, 2026 A 39,907 0 0 $0
Robert S Weiss Director April 1, 2026 A 292,599 0 0 $0
MADDEN TERESA S Director April 1, 2026 A 15,679 0 0 $0
William A Kozy Director April 1, 2025 M 31,149 0 0 $0
Gary S Petersmeyer Director March 22, 2024 G 1,523 0 0 $0
Jody S Lindell Director Jan. 6, 2023 M 13,543 0 0 $0
Michael Kalkstein Director April 1, 2020 M 0 0 0 $0
Allan E Rubenstein Director April 1, 2020 A 3,091 0 0 $0
Thomas A Bender Director April 1, 2020 A 12,952 0 0 $0
Stanley Zinberg MD Director March 12, 2019 M 10,528 0 0 $0
Steven Rosenberg Director Jan. 5, 2016 A 12,359 0 0 $0
Donald Press Director Jan. 7, 2014 A 43,970 0 0 $0
Moses Marx Director Dec. 1, 2009 A 107,532 0 0 $0
FRUTH JOHN D Director Jan. 14, 2008 A 6,500 0 0 $0
Edgar J Cummins Director Dec. 27, 2005 S 1,764 0 0 $0
COOPER COMPANIES INC Director Nov. 1, 2004 A · 0 0 $0
Cynthia L Lucchese · April 1, 2026 A 12,767 1 0 $149,963
Daniel G Mcbride · Jan. 8, 2026 M 69,352 0 0 $0
Albert G White III · Dec. 10, 2024 A 245,072 1 0 $808,000
Andrew Sedgwick · Sept. 30, 2009 M 0 0 0 $0
James M Welch · Oct. 27, 2005 A 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 100 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
KMID · Virtus ETF Trust II 2.96% 18,688 NS July 31, 2026 N-PORT
EQTY · Valued Advisers Trust 2.01% 396,156 NS July 31, 2026 N-PORT
CVSM · Elevation Series Trust 1.88% 24,508 NS July 31, 2026 N-PORT
POWA · Invesco Exchange-Traded Self-Indexe… 1.59% 45,751 SH Oct. 2, 2026 Daily
RSPH · Invesco Exchange-Traded Fund Trust 1.49% 226,573 SH Oct. 2, 2026 Daily
BSMQ · Invesco Exchange-Traded Self-Indexe… 0.73% 1,880,000 Oct. 2, 2026 Daily
QQQJ · Invesco Exchange-Traded Fund Trust … 0.56% 115,249 SH Oct. 2, 2026 Daily
FBCV · FIDELITY COVINGTON TRUST 0.45% 11,032 NS July 31, 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 0.43% 61,771 NS July 31, 2026 N-PORT
DFAT · Dimensional ETF Trust 0.37% 746,479 NS July 31, 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0.31% 85,593 NS July 31, 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0.30% 2,841,101 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.21% 586,725 SH Aug. 19, 2026 Daily
BSMU · Invesco Exchange-Traded Self-Indexe… 0.21% 545,000 Oct. 2, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.20% 92,713 NS July 31, 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0.18% 3,074,683 SH Oct. 2, 2026 Daily
SIZE · iShares Trust 0.17% 13,773 SH Sept. 11, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.17% 4,474,789 SH Aug. 19, 2026 Daily
IYH · iShares Trust 0.17% 114,003 SH Sept. 11, 2026 Daily
CURE · Direxion Shares ETF Trust 0.16% 3,839 NS July 31, 2026 N-PORT
EUSA · iShares, Inc. 0.14% 50,851 SH Sept. 11, 2026 Daily
ISCG · iShares Trust 0.14% 25,105 SH Sept. 11, 2026 Daily
IXJ · iShares Trust 0.13% 102,346 SH Sept. 11, 2026 Daily
DFSV · Dimensional ETF Trust 0.13% 142,024 NS July 31, 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0.11% 7,195 NS July 31, 2026 N-PORT
EVUS · iShares Trust 0.11% 7,759 SH Sept. 11, 2026 Daily
IWS · iShares Trust 0.10% 290,845 SH Sept. 11, 2026 Daily
EQAL · Invesco Exchange-Traded Fund Trust … 0.10% 13,955 SH Oct. 2, 2026 Daily
BSMT · Invesco Exchange-Traded Self-Indexe… 0.10% 270,000 Oct. 1, 2026 Daily
FEX · First Trust Exchange-Traded AlphaDE… 0.09% 19,651 NS July 31, 2026 N-PORT
IWR · iShares Trust 0.08% 796,790 SH Sept. 11, 2026 Daily
BAB · Invesco Exchange-Traded Fund Trust … 0.07% 592,000 Oct. 1, 2026 Daily
BSMR · Invesco Exchange-Traded Self-Indexe… 0.06% 215,000 Oct. 2, 2026 Daily
VFVA · VANGUARD WELLINGTON FUND 0.06% 7,148 SH Aug. 19, 2026 Daily
XOEF · iShares Trust 0.06% 245 SH Sept. 11, 2026 Daily
VLUE · iShares Trust 0.06% 105,585 SH Sept. 11, 2026 Daily
DXUV · Dimensional ETF Trust 0.05% 3,837 NS July 31, 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0.05% 44,755 SH Aug. 19, 2026 Daily
DFUV · Dimensional ETF Trust 0.05% 103,993 NS July 31, 2026 N-PORT
BSMS · Invesco Exchange-Traded Self-Indexe… 0.05% 155,000 Oct. 1, 2026 Daily
CHRI · Global X Funds 0.04% 47 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.04% 266,539 NS July 31, 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0.04% 117,246 SH Aug. 19, 2026 Daily
IUS · Invesco Exchange-Traded Self-Indexe… 0.04% 6,136 SH Oct. 2, 2026 Daily
IVE · iShares Trust 0.04% 325,198 SH Sept. 11, 2026 Daily
IUSV · iShares Trust 0.03% 172,535 SH Sept. 11, 2026 Daily
EGLE · Global X Funds 0.03% 10 NS July 31, 2026 N-PORT
GLBL · Pacer Funds Trust 0.03% 5 NS July 31, 2026 N-PORT
QVML · Invesco Exchange-Traded Fund Trust … 0.03% 9,255 SH Oct. 2, 2026 Daily
SUSL · iShares Trust 0.03% 6,864 SH Sept. 11, 2026 Daily
DFAS · Dimensional ETF Trust 0.03% 63,415 NS July 31, 2026 N-PORT
DSI · iShares Trust 0.03% 29,689 SH Sept. 11, 2026 Daily
DCOR · Dimensional ETF Trust 0.03% 13,489 NS July 31, 2026 N-PORT
IWD · iShares Trust 0.03% 434,725 SH Sept. 11, 2026 Daily
TILT · FlexShares Trust 0.03% 8,374 NS July 31, 2026 N-PORT
XRMI · Global X Funds 0.03% 190 NS July 31, 2026 N-PORT
CRBN · iShares Trust 0.03% 5,717 SH Sept. 11, 2026 Daily
XCLR · Global X Funds 0.03% 13 NS July 31, 2026 N-PORT
XYLG · Global X Funds 0.03% 225 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.03% 43,268 NS July 31, 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.02% 42,256 SH Oct. 2, 2026 Daily
DFSU · Dimensional ETF Trust 0.02% 7,349 NS July 31, 2026 N-PORT
XYLD · Global X Funds 0.02% 9,976 NS July 31, 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0.02% 16,763 NS July 31, 2026 N-PORT
PTLC · Pacer Funds Trust 0.02% 9,935 NS July 31, 2026 N-PORT
ACVF · ETF Opportunities Trust 0.02% 456 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.02% 61,254 NS July 31, 2026 N-PORT
XTR · Global X Funds 0.02% 14 NS July 31, 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0.02% 736 NS July 31, 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0.02% 5,069,056 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.02% 6,191,667 SH Aug. 19, 2026 Daily
VONE · VANGUARD SCOTTSDALE FUNDS 0.02% 31,957 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.02% 16,452 SH Aug. 19, 2026 Daily
ESGV · VANGUARD WORLD FUND 0.02% 43,944 SH Aug. 19, 2026 Daily
RWL · Invesco Exchange-Traded Fund Trust … 0.02% 33,906 SH Oct. 2, 2026 Daily
QDPL · Pacer Funds Trust 0.02% 4,676 NS July 31, 2026 N-PORT
TOPC · iShares Trust 0.02% 115 SH Sept. 11, 2026 Daily
XVV · iShares Trust 0.02% 2,209 SH Sept. 11, 2026 Daily
HCMT · Direxion Shares ETF Trust 0.02% 1,360 NS July 31, 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0.02% 1,151 SH Oct. 2, 2026 Daily
PBUS · Invesco Exchange-Traded Fund Trust … 0.02% 33,763 SH Oct. 2, 2026 Daily
SPXL · Direxion Shares ETF Trust 0.02% 15,254 NS July 31, 2026 N-PORT
IVV · iShares Trust 0.02% 2,459,565 SH Sept. 11, 2026 Daily
IYY · iShares Trust 0.02% 8,448 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.02% 55,887 SH Sept. 11, 2026 Daily
IWB · iShares Trust 0.02% 134,163 SH Sept. 11, 2026 Daily
VOXP · Advisors Series Trust 0.02% 12 NS July 31, 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0.01% 155 SH Oct. 2, 2026 Daily
ITOT · iShares Trust 0.01% 251,738 SH Sept. 11, 2026 Daily
TOK · iShares Trust 0.01% 564 SH Sept. 11, 2026 Daily
URTH · iShares, Inc. 0.01% 18,452 SH Sept. 11, 2026 Daily
OMFL · Invesco Exchange-Traded Self-Indexe… 0.01% 9,210 SH Oct. 2, 2026 Daily
ACWI · iShares Trust 0.01% 65,230 SH Sept. 11, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 173,475 SH Aug. 19, 2026 Daily
FTLS · First Trust Exchange-Traded Fund III -0.15% -50,276 NS July 31, 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BND · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BNDW · VANGUARD SCOTTSDALE FUNDS · · July 14, 2026 Daily
ISCB · iShares Trust · 8,790 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 25,681 SH Sept. 11, 2026 Daily

COO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 23 analysts BUY
Median target $65.50 +15.1%
6 26.1% Strong Buy
7 30.4% Buy
10 43.5% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

14 analysts · 2026-10-04

Mean target $66.21 +16.3%

← Below all targets Current price $56.91
Low$58.00 Mean$66.21 High$75.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
COO $13.70B 37.4 5.1% 9.2% 4.6% 65.5%
MDLN · -4200.0 11.5% 4.1% 21.6% 26.4%
SOLV $13.75B 8.9 0.86% 18.7% 35.8% 53.5%
ALGN $11.14B 27.6 0.90% 10.2% 10.3% 67.2%
LNTH $4.30B 19.5 0.50% 15.2% 20.7% 61.1%
MMED $3.71B -10.2 14.2% -10.7% -9.3% 54.2%
MMSI $5.24B 41.4 11.8% 8.5% 8.4% 48.7%
HAE $2.45B 26.4 -2.0% 7.3% 11.8% 59.0%
QDEL $1.99B -1.8 -1.9% -41.4% -48.0% ·
ICUI $3.52B 4755.7 -6.3% 0.03% 0.03% 36.8%

Latest News Recent headlines mentioning this company

23

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

25

No open signal right now — no card is filled, and that's honest.

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Sep 9, 2026